Cranial Irradiation for Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors

Oncologist - United States
doi 10.1634/theoncologist.2019-0152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Correction To: Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined With Chemotherapy Delay Brain Metastasis in Patients With EGFR‑Mutant Lung Adenocarcinoma

Targeted Oncology
Cancer ResearchOncologyPharmacology
2019English

Epidermal Growth Factor Receptor (EGFR): A Rising Star in the Era of Precision Medicine of Lung Cancer

Oncotarget
Oncology
2017English

AXL/epidermal Growth Factor Receptor (EGFR) Complexes in Breast Cancer - Culprits for Resistance to EGFR Inhibitors?

Breast Cancer Research
Cancer ResearchOncology
2013English

Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

MA08.02 Prophylactic Cranial Irradiation Reduces the Risk of Brain Metastases in High-Risk Lung Cancer Patients: EGFR and ALK Mutations

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Epidermal Growth Factor Receptor (EGFR) in Biliary Tract Cancer

HPB
HepatologyGastroenterology
2016English

BRAF; Epidermal Growth Factor Receptor (EGFR)

Science-Business eXchange
2012English

Improving Therapy for Patients With Epidermal Growth Factor Receptor-Mutant Lung Cancer

Cancer
Cancer ResearchOncology
2018English

Characterization of Epidermal Growth Factor Receptor ( EGFR ) P848L, an Unusual EGFR Variant Present in Lung Cancer Patients, in a Murine Ba/F3 Model

FEBS Open Bio
BiochemistryGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy